In Re Lonnie T. Spada and Joseph J. Wilczynski

911 F.2d 705, 15 U.S.P.Q. 2d (BNA) 1655, 1990 U.S. App. LEXIS 13674, 1990 WL 114330
CourtCourt of Appeals for the Federal Circuit
DecidedAugust 10, 1990
Docket90-1109
StatusPublished
Cited by64 cases

This text of 911 F.2d 705 (In Re Lonnie T. Spada and Joseph J. Wilczynski) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Lonnie T. Spada and Joseph J. Wilczynski, 911 F.2d 705, 15 U.S.P.Q. 2d (BNA) 1655, 1990 U.S. App. LEXIS 13674, 1990 WL 114330 (Fed. Cir. 1990).

Opinion

PAULINE NEWMAN, Circuit Judge.

The decision of the United States Patent and Trademark Office (the PTO) Board of Patent Appeals and Interferences (the Board), rejecting claims 2 through 25 and 27 through 31, all the claims at issue of Spada and Wilczynski (hereinafter Spada) patent application Serial No. 859,057, filed May 2, 1986 and entitled “Pressure Sensitive Adhesives and Manufactured Articles”, is affirmed.

The Invention

The Spada invention is a pressure sensitive adhesive composition comprising a water-based latex containing a normally tacky copolymer made from specified classes and proportions of monomers and having a glass transition temperature (Tg) 1 of 0°C or less. Claim 31 was treated by the parties as representative:

Claim 31. A pressure sensitive adhesive composition comprising a water-base latex comprising a continuous aqueous medium containing dispersed particles of a normally tacky polymer having a Tg of about 0°C. or less and comprising at least about 60 weight percent olefini-cally unsaturated carboxylic acid ester monomers and at least about 0.1 weight percent of at least one polymerizable functional monomer of the formula:
[[Image here]]
in which Ri is a divalent organic radical of at least 3 atoms in length, R5 and R6 are independently selected from hydrogen, hydroxy, halo, thio, amino or monovalent organic radicals, and X is -CO-R4 or -CN wherein R4 is hydrogen or a monovalent organic radical.

The Spada disclosure broadly is coextensive with claim 31. While claim 31 requires that the polymers comprise members of two general classes of monomers, Spada’s specific examples illustrate polymers in which members of three general classes of monomers are present.

The first class of monomer required by Spada is an olefinically unsaturated carbox-ylic acid ester that is present in at least about 60 weight percent of the polymer. Representative examples show 96.5 weight percent butyl acrylate (Example 2), and a combination of 48 weight percent butyl acrylate and 48 weight percent 2-ethylhex-yl acrylate (Example 11).

Spada’s second required class of monomer is a “polymerizable functional monomer” present in “at least about 0.1 weight percent” of the polymer (claim 31); The illustrative examples show 1-2 weight percent acetoacetoxyethyl methacrylate (AAE-MA).

Spada’s specification states that preferred polymer compositions include at least about 0.1 weight percent of a third *707 class of monomer, an olefinically unsaturated carboxylic acid. Examples are 1.5 weight percent methacrylic acid (Example 2) and 3 weight percent acrylic acid (Example 7).

All of Spada’s claims require that the Tg of the claimed tacky polymers is about 0°C or less, and that the products are pressure-sensitive adhesives.

The claims were rejected as unpatentable in view of the Smith reference, United States Patent No. 3,554,987, issued January 12,1971. The Spada disclosure and the Smith reference both show polymers of the same monomers, in overlapping ratios of components. However, the products that Smith and Spada obtain are described as quite different.

The Smith Reference

Smith describes water-based latexes containing dispersed particles of polymers made from certain classes and proportions of monomers. The polymers are used in binding agents in photographic gels and films.

In most of Smith’s examples three monomers are present, as in Spada’s examples. The first monomer in Smith’s preferred polymers is an olefinically unsaturated car-boxylic acid ester, in at least 50 percent by weight of polymer. In Smith’s examples this component is illustrated, inter alia, as 75.7 molar percent butyl acrylate (Example 5), and 72.4 weight percent ethyl acrylate (Example 15).

Smith’s second monomer used in preparing his preferred polymers is a polymeriza-ble functional monomer like that described by Spada, present in about 2-20 weight percent of the polymer. Smith’s examples include polymers containing 9.4 molar percent of aeetoacetoxyethyl acrylate (AAEA) (Example 5), and 3.5 weight percent AAE-MA (Example 15). Spada incorporated by reference the entire disclosure of the Smith patent, as showing polymerizable functional monomers suitable and preferred for use in the Spada polymers, and the preparation of these monomers.

The preferred polymers of Smith contain a third monomer, as do Spada’s, and most of Smith’s examples include acrylic acid. Thus, in Smith’s Example 5 the complete polymer composition is 75.7 molar percent butyl acrylate, 9.4 molar percent AAEA, and 14.9 molar percent acrylic acid. In Smith’s Example 15 the composition is 72.4 weight percent ethyl acrylate, 3.5 weight percent AAEMA, and 24.1 weight percent acrylic acid.

Smith states that emulsions containing his polymers have improved properties of hardness, resistance to abrasion, good adhesion, and dimensional stability. Smith does not show or suggest that his polymer latexes can form a normally tacky pressure-sensitive adhesive — properties admitted to be different from hardness and abrasion resistance..

Discussion

The Board affirmed the rejection of Spa-da’s claims under 35 U.S.C. §§ 102, 103, this hybrid rejection having apparently been made on the theory that if the claimed subject matter was novel, i.e. not anticipated, in terms of section 102, then it would have been obvious under section 103. 2 The Commissioner on this appeal concentrates on the rejection for anticipation. The Commissioner argues that a prima facie case 3 of anticipation is made by the Smith disclosure of polymers that are apparently identi *708 cal to those of Spada, although the properties described by Smith are different from those that are reported by Spada and included as express limitations in Spada’s claims.

Rejection for anticipation or lack of novelty requires, as the first step in the inquiry, that all the elements of the claimed invention be described in a single reference. Richardson v. Suzuki Motor Co., 868 F.2d 1226, 1236, 9 USPQ2d 1913, 1920 (Fed.Cir.), cert. denied, — U.S. -, 110 S.Ct. 154, 107 L.Ed.2d 112 (1989). Further, the reference must describe the applicant’s claimed invention sufficiently to have placed a person of ordinary skill in the field of the invention in possession of it. Akzo N.V. v. United States Int’l Trade Comm’n, 808 F.2d 1471, 1479, 1 USPQ2d 1241, 1245 (Fed.Cir.1986), cert. denied, 482 U.S. 909, 107 S.Ct. 2490, 96 L.Ed.2d 382 (1987); In re Coker, 463 F.2d 1344, 1348, 175 USPQ 26, 29 (CCPA 1972).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re EARLEY
Federal Circuit, 2020
Hyatt v. Matal
District of Columbia, 2018
Hyatt v. Iancu
332 F. Supp. 3d 83 (D.C. Circuit, 2018)
Tf3 Limited v. Tre Milano, LLC
894 F.3d 1366 (Federal Circuit, 2018)
Emerachem Holdings, LLC v. Volkswagen Group of America, Inc.
714 F. App'x 995 (Federal Circuit, 2017)
In Re: Chudik
674 F. App'x 1011 (Federal Circuit, 2017)
Howmedica Osteonics Corp. v. Zimmer, Inc.
640 F. App'x 951 (Federal Circuit, 2016)
Sd3, LLC v. Dudas
952 F. Supp. 2d 97 (District of Columbia, 2013)
In Re Mousa
479 F. App'x 348 (Federal Circuit, 2012)
Byrne v. Wood, Herron & Evans, Llp.
450 F. App'x 956 (Federal Circuit, 2011)
Tyco Healthcare Group LP v. Mutual Pharmaceutical Co.
642 F.3d 1370 (Federal Circuit, 2011)
Volterra Semiconductor Corp. v. Primarion, Inc.
796 F. Supp. 2d 1025 (N.D. California, 2011)
Laboratory Skin Care, Inc. v. Limited Brands, Inc.
661 F. Supp. 2d 473 (D. Delaware, 2009)
In Re Gleave
560 F.3d 1331 (Federal Circuit, 2009)
In Re Sujeet Kumar
418 F.3d 1361 (Federal Circuit, 2005)
In Re Aventis Pharmaceuticals, Inc.
372 F. Supp. 2d 430 (D. New Jersey, 2005)
In Re Crish
Federal Circuit, 2004

Cite This Page — Counsel Stack

Bluebook (online)
911 F.2d 705, 15 U.S.P.Q. 2d (BNA) 1655, 1990 U.S. App. LEXIS 13674, 1990 WL 114330, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-lonnie-t-spada-and-joseph-j-wilczynski-cafc-1990.